Astradyne
AS
AS

Astradyne

Agent22Agent Readiness: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 41.

Astradyne is a startup focused on developing advanced AI for scientific discovery and research.

Website
2023InactiveSan Francisco, United States

About

Astradyne is an early-stage company leveraging artificial intelligence to accelerate scientific research and discovery. Their technology aims to assist researchers in areas such as drug discovery, materials science, and complex data analysis, by providing powerful AI-driven tools and insights.

Key facts

At-a-glance profile data

Website
astradyne.ai
Headquarters
San Francisco, United States
Founded
2023
Total funding
$2M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Astradyne
DateRoundAmountLead investors
17 Jan 2025Seed$2M4WARD VC
Add first review

Frequently asked

How much funding has Astradyne raised?

Astradyne has raised a total of $2M in funding. The most recent round on record is Seed.

What is Astradyne's current status?

Astradyne's current operating status is: Inactive.